Lactose India (LACTOSE) | Stock Overview & Key Data
Lactose India Performance Comparison
Stock Range
Today's Range
Low: ₹89.99
High: ₹101.00
on August 22, 2025
52 Week Range
Low: ₹84.27
High: ₹247.40
on April 1, 2025
on December 10, 2024
All-Time High: ₹247.40 on December 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.2B
EPS
4.06
P/E Ratio (TTM)
22.87
Forward P/E
N/A
P/B Ratio
1.99
PEG Ratio
N/A
Div. Yield
N/A
ROE
8.79%
Beta
0.491
Debt to Equity
96.75
Financial Highlights
Profitability
Gross Margin
34.06%
Operating Margin
7.82%
Profit Margin
3.47%
Returns and Earnings
Return on Assets (TTM)
3.87%
Return on Equity (TTM)
8.79%
EBITDA
INR184.1M
Net Income (TTM)
INR43.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR100.49
Quarterly Revenue Growth (YoY)
34.30%
Quarterly Earnings Growth (YoY)
-34.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lactose India LACTOSE | 1.17B Small-cap | 2.75% | 1.26% | -2.43% | -16.76% | -54.72% | -37.72% | 39.89% | 295.66% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 0.56% | -2.16% | -4.47% | 0.14% | -13.13% | -7.54% | 86.54% | 195.42% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -0.21% | -6.98% | -5.91% | 7.87% | 1.29% | 26.68% | 71.47% | 87.96% |
| Sun Pharma Advanced SPARC | 47.77B Small-cap | 1.72% | -7.23% | -10.11% | 14.74% | -27.21% | -34.43% | -37.13% | -23.18% |
| Aarti Drugs AARTIDRUGS | 42.99B Small-cap | -4.13% | -10.00% | 1.76% | 27.10% | 6.05% | -14.34% | 10.27% | -34.08% |
| Sequent Scientific SEQUENT | 44.30B Small-cap | 0.12% | -6.92% | -2.35% | 12.64% | -4.77% | 5.41% | 52.52% | 30.60% |
Ownership & Short Interest
Insider Ownership
58.85%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
9K
Average 90-Day Volume
6K
Lactose India Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Lactose India would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LACTOSE's 52-week high and low?
- In the last 52 weeks, Lactose India reached a high of ₹247.40 (on December 10, 2024) and a low of ₹84.27 (on April 1, 2025).
- What is the market cap and P/E ratio for LACTOSE?
- Curious about Lactose India's size and valuation? Its market capitalization stands at 1.17B. When it comes to valuation, the P/E ratio (trailing twelve months) is 22.87, and the forward P/E (looking ahead) is N/A.
- Does LACTOSE pay dividends? If so, what's the yield?
- As for dividends, Lactose India isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Lactose India's main competitors or similar companies to consider before investing?
When looking at Lactose India, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -7.54% 86.54% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.68% 71.47% Sun Pharma Advanced
SPARC47.77B Healthcare Drug Manufacturers - Specialty & Generic -34.43% -37.13% Aarti Drugs
AARTIDRUGS42.99B Healthcare Drug Manufacturers - Specialty & Generic -14.34% 10.27% Sequent Scientific
SEQUENT44.30B Healthcare Drug Manufacturers - Specialty & Generic 5.41% 52.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lactose India Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Lactose India's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.79%, the Debt to Equity ratio from the most recent quarter is 96.75, and its Gross Profit Margin stands at 34.06%.
- What is the recent revenue and earnings growth for LACTOSE?
- Looking at Lactose India's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 34.30%, and quarterly earnings saw a YoY growth of -34.00%.
- How much of LACTOSE stock is held by insiders and institutions?
- Wondering who owns Lactose India stock? Company insiders (like executives and directors) hold about 58.85% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.